Clinical trial registry record

Skin Rejuvenation Using Stem Cell Secretome

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Completed.
Evidence
Registered phase 1 study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 6, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT06217627
Last registry update
February 6, 2024
Status
Completed
Phase
Phase 1
Sponsor
COR clinic of Regenerative Medicine
Enrollment
49
Countries
Lebanon
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered PHASE1 study indexed because it matched monitored longevity research terms. Registry status: Completed. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase 1
Study design
RANDOMIZED · SINGLE GROUP · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
49
Population
FEMALE · 25 Years
Duration
2021-03-05 to 2023-06-30
Intervention
secretome
Comparator
Not reported
Outcomes measured
Selected growth factors assessment — 4 samples of secretome extracted from UC-explants with one week interval. 1 sample…; Wrinkle severity in hands — digital photographs before injection and after 7 months.; Wrinkle severity in the face and neck — digital photographs before injection and after 7 months.; Histological examination — skin biopsies were performed at two moments: before treatment and after 12 months.
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase 1A trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Stem cells · 100%Title contains controlled term: stem cell. Abstract contains controlled term: stem cell. Title supplies longevity context: rejuvenation. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

stem cells
Open primary sourceExport JSON